Global Contrast-Enhanced Ultrasound Industry in 2022 was US$ 2,700 million and is estimated to be US$ 5,243.3 million in 2023. Future Market Insights has mentioned in its reports that the contrast-enhanced ultrasound industry will expand at a CAGR of 5.8% between 2023 and 2033, totaling around US$ 9,214.3 million by.
SonoThera and Janssen Pharmaceuticals, Inc. have entered into a research collaboration agreement to develop a novel approach for delivering nucleic acid-based.
SonoThera™ to Present Preclinical Data on Use of Its Ultrasound-Guided Gene Therapy Platform at the 2023 ASGCT Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Bracco Imaging S.p.A., a global leader in diagnostic imaging, and SonoThera, Inc., a biotechnology company dedicated to treating the root cause.
Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.